Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

Psychiatry Research

Volumn 176, Issue 1, 2010, Pages 85-87

  Illi, Ari ^a,c   Setälä Soikkeli, Eija ^c   Kampman, Olli ^a,d   Viikki, Merja ^a   Nuolivirta, Timo ^d   Poutanen, Outi ^b   Huhtala, Heini ^e   Mononen, Nina ^b   Lehtimäki, Terho ^b   Leinonen, Esa ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c KANTA HÄME CENTRAL HOSPITAL   (Finland)

^d SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF TAMPERE   (Finland)

Author keywords

COMT; MDD; SSRIs

Indexed keywords

CATECHOL METHYLTRANSFERASE; CITALOPRAM; FLUOXETINE; METHIONINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; VALINE;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FINLAND; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

CATECHOL O-METHYLTRANSFERASE; DEPRESSIVE DISORDER, MAJOR; FINLAND; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; METHIONINE; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN UPTAKE INHIBITORS; VALINE;

EID: 76749099733     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.03.010     Document Type: Article

References (13)

1. Arias B., Serretti A., Lorenzi C., Gastó C., Catalán R., and Fañanás L. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. Journal of Affective Disorders 90 (2006) 251-256
2. Baune B., Hohoff C., Berger K., Neumann A., Mortensen S., Roehrs T., Deckert J., Arolt V., and Domschke K. Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 33 (2008) 924-932
3. Cusin C., Serretti A., Lattuada E., Lilli R., Lorenzi C., and Smeraldi E. Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. American Journal of Medical Genetics, 114 (2002) 380-390
4. Frisch A., Postilnick D., Rockah R., Michaelovsky E., Postilnick S., Birman E., Laor N., Rauschverger B., Kreinin A., Poyurovsky M., Schneidman M., Modai I., and Weizman R. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Molecular Psychiatry 4 (1999) 389-392
5. Kunugi H., Vallada H.P., Hoda F., Kirov F., Aittchison K.J., Ball D., Arranz M.J., Murray R.M., and Collier D.A. No evidence for an association of affective disorders with high-or low-activity allele of catechol-O-methyltransferase. Biological Psychiatry 42 (1997) 282-285
6. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 (1996) 243-250
7. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
8. Massat I., Souery D., Del-Favero J., Nothen M., Blackwood M., Muir W., Kaneva R., Serretti A., Lorenzi C., Rietschel M., Milanova V., Papadimitriou G.N., Dikeos D., Van Broekhoven C., and Mendlewicz J. Association between COMT (Val158Met) functional polymorphism and early onset in patients with major Depressive disorder in a European multicenter genetic association study. Molecular Psychiatry 10 (2005) 598-605
9. McMahon F.J., Buervenich S., Charney D., Lipsky R., Rush A.J., Wilson A.F., Sorant A.J.M., Papanicolau G.J., Laje G., Fava M., Trivedi M.H., Wisniewski S.R., and Manji H. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. The American Journal of Human Genetics 78 (2006) 804-814
10. Ohara K., Nagai M., Suzuki Y., and Ohara K. Low activity allele of catechol-O-methyltransferase gene and Japanese unipolar depression. Neuroreport 9 (1998) 1305-1308
11. Serretti A., Rotondo A., Lorenzi C., Smeraldi E., and Cassano G.B. Catechol-O-methyltransferase gene variants in mood disorder in the Italian population. Psychiatric Genetics 16 (2006) 181-182
12. Szegedi A., Rujescu D., Tadic A., Muller M.J., Kohnen R., Stassen H.H., and Dahmen N. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. The Pharmacogenomics Journal 5 (2005) 49-53
13. Yoshida K., Higuchi H., Takahashi H., Kamata M., Sato K., Inoue K., Suzuki T., Itoh K., and Ozaki N. Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran. Human Psychopharmacology 23 2 (2008) 121-128